Page last updated: 2024-10-30

mesalamine and Shock

mesalamine has been researched along with Shock in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research Excerpts

ExcerptRelevanceReference
"We report a case of Crohn's disease in a 32-year old Saudi male."1.31Crohn's disease presenting as life-threatening ileal bleeding. ( Ahmad, TM; Al-Been, H; De Keersmaecker, J; Tysk, C, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tysk, C1
De Keersmaecker, J1
Al-Been, H1
Ahmad, TM1

Other Studies

1 other study available for mesalamine and Shock

ArticleYear
Crohn's disease presenting as life-threatening ileal bleeding.
    Saudi medical journal, 2000, Volume: 21, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colectomy; Colonic Diseases; Critical Illnes

2000